Novo Nordisk A/S ADR buy BiotechBee
Start price
07.09.22
/
70%
€104.00
Target price
31.12.25
€180.00
Performance (%)
41.35%
End price
05.05.23
€147.00
Summary
This prediction ended on 05.05.23 with a price of €147.00. With a performance of 41.35% the BUY prediction by BiotechBee was a big success. Dividends of €1.10 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 6.592% | 6.592% | -57.990% | -65.992% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% | 69.888% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% | 101.814% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% | 45.300% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% | 63.763% |
According to BiotechBee what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Buy mit Kursziel 180,0